6-24654466-TTG-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_016614.3(TDP2):c.580_581del(p.Gln194ArgfsTer25) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 33)
Consequence
TDP2
NM_016614.3 frameshift
NM_016614.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.29
Genes affected
TDP2 (HGNC:17768): (tyrosyl-DNA phosphodiesterase 2) This gene encodes a member of a superfamily of divalent cation-dependent phosphodiesterases. The encoded protein associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor associated factors (TRAFs), and inhibits nuclear factor-kappa-B activation. This protein has sequence and structural similarities with APE1 endonuclease, which is involved in both DNA repair and the activation of transcription factors. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 6-24654466-TTG-T is Pathogenic according to our data. Variant chr6-24654466-TTG-T is described in ClinVar as [Pathogenic]. Clinvar id is 2598969.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TDP2 | NM_016614.3 | c.580_581del | p.Gln194ArgfsTer25 | frameshift_variant | 5/7 | ENST00000378198.9 | NP_057698.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TDP2 | ENST00000378198.9 | c.580_581del | p.Gln194ArgfsTer25 | frameshift_variant | 5/7 | 1 | NM_016614.3 | ENSP00000367440 | P1 | |
TDP2 | ENST00000341060.3 | c.406_407del | p.Gln136ArgfsTer25 | frameshift_variant | 4/6 | 1 | ENSP00000345345 | |||
TDP2 | ENST00000478285.1 | n.767_768del | non_coding_transcript_exon_variant | 3/3 | 2 | |||||
TDP2 | ENST00000478507.1 | n.320-1315_320-1314del | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2023 | The c.580_581delCA (p.Q194Rfs*25) alteration, located in exon 5 (coding exon 5) of the TDP2 gene, consists of a deletion of 2 nucleotides from position 580 to 581, causing a translational frameshift with a predicted alternate stop codon after 25 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the available evidence, this alteration is classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.